Icahn School of Medicine at Mount Sinai Hospital — New York, New York

Icahn School of Medicine at Mount Sinai Hospital is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Icahn School of Medicine at Mount Sinai Hospital has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Fragile X Syndrome, Crohn Disease, Vanishing Twin.

Sponsors: Tetra Discovery Partners, Intralytix, Inc., Natera, Inc..

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Icahn School of Medicine at Mount Sinai Hospital?

Icahn School of Medicine at Mount Sinai Hospital has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Icahn School of Medicine at Mount Sinai Hospital conducted?

Icahn School of Medicine at Mount Sinai Hospital has 4 clinical trials on record, with 1 currently active. Their work covers Fragile X Syndrome, Crohn Disease, Vanishing Twin.

Is Icahn School of Medicine at Mount Sinai Hospital accredited by Crixeo Health?

Icahn School of Medicine at Mount Sinai Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Icahn School of Medicine at Mount Sinai Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.